Shang‐Chiung Chen

First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors

Tae Won Kim, Howard A. Burris, Maria J. de Miguel et al. · Clinical Cancer Research · 2022 · 79 citations · Full text

Clinical pharmacology of vc-MMAE antibody–drug conjugates in cancer patients: learning from eight first-in-human Phase 1 studies

Chunze Li, Cindy Zhang, Zao Li et al. · mAbs · 2019 · 53 citations · Full text

Nano-scale liquid chromatography/mass spectrometry and on-the-fly orthogonal array optimization for quantification of therapeutic monoclonal antibodies and the application in preclinical analysis

Xiaotao Duan, Li-peng Dai, Shang‐Chiung Chen et al. · Journal of Chromatography A · 2012 · 47 citations · Full text

Engineering, Therapeutic Monoclonal Antibodies, Bioanalysis +12

Biochemical Properties and cDNa Cloning of Two New Lectins from the Plasma of Tachypleus tridentatus

Shang‐Chiung Chen, Chon‐Ho Yen, Maw-Sheng Yeh et al. · Journal of Biological Chemistry · 2001 · 46 citations · Full text

Exposure–response analyses of trastuzumab emtansine in patients with HER2-positive advanced breast cancer previously treated with trastuzumab and a taxane

Chunze Li, Bei Wang, Shang‐Chiung Chen et al. · Cancer Chemotherapy and Pharmacology · 2017 · 28 citations

Breast Oncology, Medicine, Pathology +7